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Abstract
Introduction: The cardiac bioprostheses are related to
thromboembolic events, infectious and degenerative
diseases. Wear is mainly attributed to the denaturation of
collagen. Glutaraldehyde, the predominant method of
preservation of bioprostheses, favors the calcification process
and limits their durability. Several techniques try to contain
the degenerative process of bioprostheses.
Objectives: To evaluate the process of calcification in vivo
pulmonary valve heterografts preserved in non-aldehydic
(L-Hydro®).
Methods: Seventeen sheep underwent replacement of
the pulmonary artery valved tubular grafts of bovine
pericardium. The animals were divided into two groups:
Group L-Hydro® (test / n = 14) and Group Glutaraldehyde
(control / n = 3). About 150 days after implantation the
animals were sacrificed, necropsied and implants subjected
to a pathological study, radiological evaluation and
measurement of calcium by atomic absorption
spectrophotometry. Statistical analysis was obtained through
the Fisher’s exact test, Student’s t or Mann-Whitney test
(significance: 5%).
Results: The radiological evaluation, the macroscopic and
microscopic measurement of serum calcium by atomic
absorption spectrophotometry showed increased calcification
of the prosthetic group Glutaraldehyde, when compared to
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denture-HydroR Group L (P = 0.001). Seven animals in Group
L-Hydro® (50%) had adherence of the leaflets to the wall of
the tube (P = 0.228).
Conclusions: Prostheses preserved in L-Hydro® were
more resistant to calcification when compared with
glutaraldehyde preserved.
Descriptors: Bioprosthesis. Glutaral. Polyethylene
glycols. Heart valve prosthesis. Heart valve diseases/surgery.
Resumo
Introdução: As biopróteses valvares cardíacas estão
relacionadas a eventos tromboembólicos, infecciosos e
degenerativos. Seu desgaste é atribuído principalmente à
desnaturação do colágeno. O glutaraldeído, método
predominante de preservação de biopróteses, favorece o processo
de calcificação e limita sua durabilidade. Diversas técnicas
tentam conter o processo degenerativo das biopróteses.
Objetivo: Avaliar o processo de calcificação, in vivo, de
heteroenxertos pulmonares valvados, preservados em meio
não-aldeídico (L-Hydro®).
Métodos: Dezessete carneiros foram submetidos à
substituição do tronco da artéria pulmonar por enxerto
tubular valvado de pericárdio bovino. Os animais foram
distribuídos em dois grupos: Grupo L-Hydro® (teste / n=14)
e Grupo Glutaraldeído (controle /n=3). Cerca de 150 dias
pós-implante os animais foram sacrificados, necropsiados e
as próteses submetidas a estudo anatomopatológico, avaliação
radiológica e dosagem do cálcio por espectrofotometria de
absorção atômica. A análise estatística foi obtida por meio
dos testes exato de Fisher, T de Student ou Mann-Whitney
(significância: 5%).
Resultados: A avaliação radiológica, macroscopia,
microscopia e dosagem de cálcio por espectrofotometria de
absorção atômica demonstraram maior calcificação nas
próteses do Grupo Glutaraldeído, quando comparadas às
próteses do Grupo L-Hydro® (P=0,001). Sete animais do
Grupo L-Hydro® (50%) apresentaram aderência das
cúspides à parede do tubo (P=0,228).
Conclusões: As próteses preservadas em L-Hydro®
demonstraram-se mais resistentes à calcificação, quando
comparadas às preservadas em glutaraldeído.
Descritores: Bioprótese. Glutaral. Polietilenoglicóis.
Próteses valvulares cardíacas. Doenças das valvas cardíacas/
cirurgia.
INTRODUCTION
Patients with heart valve disease, surgical treatment
when indicated, deal with an important and sensitive issue
- the choice of valve replacement. The existing substitute
valve, however, has significant limitations. Because they
are foreign tissue to the human body, valve prostheses are
associated with the risk of thromboembolic complications,
degenerative and infectious diseases [1]. While mechanical
prostheses, highly thrombogenic, requires long-term
anticoagulant therapy, the bioprostheses, whether
cryopreserved or fixed in glutaraldehyde, have limited
durability dysfunction caused mainly by progressive tissue
degeneration. The degeneration of bioprostheses continues
to figure among the main issues surrounding the treatment
of patients with valvular heart disease. The search for the
manufacture of valve replacement through tissues has been
the subject of studies by many authors over the last sixty
years [2-8]. In an attempt to reduce the wear rate and thus
prolong the life of prostheses, some preservation
techniques have been proposed in order to reduce the
calcification process [9-15]. The bioprostheses commonly
are preserved in glutaraldehyde. This method is associated
with greater aggregation of fibrin, macrophages, calcium,
and thrombotic material to the surface of the prosthesis
[16,17]. Glutaraldehyde contained on the surface of the
prosthetic tissue is cytotoxic. The main disadvantage of
glutaraldehyde fixation of bioprostheses is the resulting
tissue calcification over time [1,16,17], which favors the
dysfunction and the need for surgical replacement of the
prosthesis. The current challenge of tissue engineering is
to study and propose the creation of replacement tissue
and heart valves from biological and artificial structures
that are biocompatible, non-thrombogenic, non-teratogenic,
Abreviaturas, acrônimos e símbolos
PEG Polietilenoglicol
SPSS Statistical Package for the Social Sciences
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durable and permit monitoring of the growth of the host
[18-20]. Theoretically, the alternative would be to use the
prosthesis, treated, allow spontaneous epithelialization with
host cells [21].
Nina et al. in 2005 [22] and Santos et al. in 2007 [23]
tested the method of preservation in L-HydroR (PEG). The
first two prostheses compared by this method with
glutaraldehyde preserved bioprosthesis implanted in the
mitral and aortic valves, respectively, in juvenile sheep.
The prostheses treated conventionally with glutaraldehyde
showed macroscopic and microscopic calcification, and
deposition of thrombotic material. Those already preserved
in L-HydroR had spontaneous repopulation by host cells,
conferring greater resistance to calcification and
thrombogenicity. Rey et al. in 2011 [24] compare
morphologically and functionally preserved pulmonary
homograft L-HydroR method, with the fresh homograft
implanted in juvenile sheep, and evaluated after a period of
320 days. The authors concluded that the homograft treated
by L-HydroR method showed histological evidence of
interstitial and endothelial cell repopulation. Recently,
Furlanetto et al. in 2009 (25) demonstrated that porcine
pulmonary xenograft with L-HydroR preservation placed in
the pulmonary position of sheep newborns and followed
into adulthood presents growth of the graft, absence of
calcification and preservation of pulmonary valve function.
In this context, this study advances in the evaluation of
the process of spontaneous endothelialization of valve
replacement, this time testing the performance of the model
for preservation polyethylene (L-HydroR) in valved tubular
prosthesis implanted in the pulmonary artery of sheep.
Objective
Evaluate the processes of structural degeneration in
vivo pulmonary valve heterografts preserved in L-HydroR
and implanted in sheep, with a minimum observation period
of five months.
METHODS
The study was approved by the Ethics Committee of
UNIFESP. Fourteen (14) animals received implantation of
the bioprosthesis to be tested (L-HydroR) L- HydroR group
(test). Three (03) animals received implants of
glutaraldehyde preserved bioprosthesis control -
Glutaraldehyde group (control). Animals that died before
24 hours after surgery were considered surgical deaths and
were excluded from the study. Additional animals were
included in the study. Animals that died before the
scheduled date of sacrifice were examined and necropsied.
The prosthesis is used in a patch of corrugated bovine
pericardium treated by L-HydroR. The closing of the tube is
made with two suture lines. A valve made of bovine
pericardium, treatment with L-HydroR is fixed inside the
tube. Once assembled, the pipe is tested for the competence
of the valve and not checked for leaks. Approved, the
prosthesis is sterilized in a solution of hydrogen peroxide
and ethanol and then packed in a solution of 50% ethanol.
Sterility testing is done using samples incubated in culture
media FTM, Middlebrook and STB for 14 days.  As soon
the is proven sterility, the prosthesis is released. The
preservation technique in L-HydroR consists of three
distinct steps: STEP 1: Extraction of the antigens and
chemical oxidation of the remaining antigens with
polyethylene glycol; STEP 2: Sterilization in hydrogen
peroxide; STEP 3: Inventory of the prostheses in ethanol
solution at 50%.
The animals were left fasting 24 hours before surgery.
Anesthetic induction was done with Thiopental (IV). The
animal was intubated, placed on mechanical ventilation,
nasogastric tube passed, electrocardiographic monitoring
and shaving the left chest. From a left thoracotomy at the
fourth intercostal space, the left lung was removed, made
the opening of the pericardial sac and dissection of the
pulmonary trunk. Heparinization was performed after
cannulation of the ascending aorta and right atrium with
the establishment of cardiopulmonary bypass with total
hemodilution, normothermia and without aortic clamping.
After complete division of the pulmonary trunk, the native
pulmonary valve leaflets were removed. A segment of the
graft of approximately 4 cm, containing the cusp was
anastomosed to the proximal portion of the outflow of the
right ventricle and the pulmonary trunk portion related to
the bifurcation, with a continuous suture using 5-0
polypropylene thread. After hemostasis, CPB was
discontinued. After replacement of the entire blood volume
of the cannulas were removed and administered protamine
chloride. A chest drain was placed, the pericardium and the
thoracic incision closed approx. The drain was removed
when the animal begins to breathe spontaneously. The
animal was left under observation for a period of 07 days,
after which it was refered to the vivarium after surgery.  The
animal continued to be observed and evaluated daily during
the predetermined period of 150 days, or while he survived.
Evaluation of hematological and biochemical blood was
held on the 7th and 90th postoperative day, and the day of
sacrifice.
After sacrifice with an injection of potassium chloride,
the prostheses were explanted and subjected to
macroscopic evaluation. After fixation in 10%
formaldehyde, the histological study was conducted to
evaluate the deposition of calcium and thrombotic material
on the surface of the prosthesis. Bioprostheses were cut,
dehydrated in alcohol, embedded in paraffin and sectioned
in four micromeres fragments and then were treated with
hematoxylin-eosin for evaluation of calcium deposits. The
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slides were observed under an optical microscope by a
pathologist without knowing that the group would be
analyzing (assessment “blind”). Both macroscopic and
microscopic evaluation, the degree of calcification was
quantified (semi quantitative assessment) by considering
the anatomopathological examination graduation: 0 - absent
calcification, 1 - mild calcification, 2 - moderate calcification,
3 – Important calcification .
The autopsies were performed in all cases. Samples were
collected using swabs for bacteriology. The samples were
subjected to radiological examination to determine the
distribution and intensity of calcium deposits in the valve
leaflets, as well as the tube, and used a Senographe DMR
mammography unit (GE, Buc. France). The degree of
calcification was rated from zero to three (0-3). Fragments
of the tube and the leaflets were dehydrated in an oven at
50°C and mineralized in muffle furnace at 800oC, dissolved
in nitric acid (HNO3 - 2.5 M) determined the amount of
calcium (expressed as ug / mg dry tissue) by method of
atomic absorption spectrophotometry, using the Perkin
Elmer spectrophotometer of 1.000 mg/L with addition of
1% lanthanum chloride (Baucia et al., 2006).
All categorical data are expressed as proportions,
whereas quantitative variables are expressed as mean ±
standard deviation. Histograms were made to assess the
normal distribution of quantitative data. We chose to use
Fisher’s exact test to compare the observed frequencies in
L-HydroR Group (test group) with the frequencies observed
in the glutaraldehyde group (control group). To compare
quantitative data between groups (cases versus controls),
the Student t test or Mann-Whitney test were used when
appropriate. The significance level was preset at 5%. The
software used was SPSSR.
RESULTS
Nineteen animals underwent the procedure for replacing
the pulmonary valved tubular graft. The operative mortality
rate was 10.53% (two animals). The cause of death was
hypovolemic shock secondary to intra-operative bleeding.
The seventeen remaining animals were included in the
study. Chart 1 summarizes the information related to the
study.
In Group L-HydroR Group, two animals died before
sacrifice. The first, on the 86th postoperative day, the cause
of death was endocarditis, confirmed by autopsy. The
second animal was found dead on the 165th postoperative
day, while waiting for the sacrifice. Autopsy showed no
Chart 1. Surgical data
L-Hydro® group
1
2
3
4
5
6
7
8
9
10
11
12
16
17
Glutaraldehyde group
13
14
15
Gender
F
M
F
M
M
M
M
M
M
M
M
M
F
M
Gender
M
M
M
Weight
(kg)
34
30
35
30
27
30
35
35
33
33
32
32
30
28
Weight
(kg)
35
33
33
Age
(months)
8.13
7.93
6.77
6.13
6.20
7.37
6.73
6.73
6.60
6.67
6.77
6.77
7.67
8.33
Age
(months)
6.30
6.30
6.50
CPB
(min)
76
93
79
76
62
100
49
71
48
28
34
30
39
35
CPB
(min)
38
30
25
Survival
(days)
165
197
194
151
168
174
162
162
86
161
161
162
154
154
Survival
(days)
161
161
161
Size
Prosthesis
17
17
17
17
15
17
17
17
17
17
17
17
19
19
Size
Prosthesis
17
17
17
Status
Death
Sacrificed
Sacrificed
Sacrificed
Sacrificed
Sacrificed
Sacrificed
Sacrificed
Death
Sacrificed
Sacrificed
Sacrificed
Sacrificed
Sacrificed
Status
Sacrificed
Sacrificed
Sacrificed
M = male, F = female. CPB – Cardiopulmonary bypass
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evidence of endocarditis. There were, however, signs of
respiratory infection in the right lung (congestion and
edema).
The detection of calcifications, mammographic
technique, the prosthesis preserved in L-HydroR, was limited
to the sewing area of the prosthesis (Figure 1).  As the
prosthesis was already preserved in glutaraldehyde, the
calcification occurred in all prostheses and spread to the
wall of the tube and the valve leaflets (Figure 2). The case
13 showed calcification moderate (grade 2) and cases 14
and 15, significant calcification (grade 3) (Table 1).
Table 1. Measurement of calcification: 0 - no calcification, 1 -
mild calcification; 2 - moderate calcification, 3 -
significant calcification.
L-Hydro® group
1
2
3
4
5
6
7
8
9
10
11
12
16
17
Glutaraldehyde
group
13
14
15
Calcification of leaflet
mammography
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Calcification of leaflet
mammography
2
3
3
Calcification of tube
mammography
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Calcification of tube
mammography
2
3
3
Fig. 1 - Appearance radiological graft preserved in L-Hydro ®
(no calcification)
Fig. 2 - Radiological Appearance of prosthesis preserved in
glutaraldehyde (diffuse calcification)
Table 2. Statiscal analysis of mammography (L-Hydro® and Glutaraldehyde groups).
Variable*
Calcification (moderate / significant) of
leaflets (mammography)
Calcification (moderate / significant) of
the tube (mammography)
L-Hydro®
group (n=14)
__
__
Glutaraldehyde group
(n=3)
3 (100%)
3 (100%)
P Value†
0.001
0.001
Statistical analysis revealed significant difference (P =
0.001) compared between groups and L-HydroR
Glutaraldehyde, as shown in Table 2.
Macroscopic evaluation of all prostheses in
Glutaraldehyde Group showed gross calcification of the
leaflets and the tube. In two of these prostheses
calcification was classified as severe. But among the
prostheses in L-HydroR Group two (14.3%) showed
calcification quantified as mild, tube. Only in one leaflet of
a prosthesis was verified the presence of calcification,
quantified as mild (Table 3).
Another finding was observed in the macroscopic partial
or total adherence of the leaflets to the wall of the tube
(Figure 3). This occurred in seven (50%) animals, all in L-
HydroR Group. In three animals (21.4%), all the prosthetic
leaflets were attached to the tube wall. Two animals (14.3%)
had adhered hum of brochures and other two animals
(14.3%), two leaflets were attached to the tube wall. There
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Table 3. Measurement of calcification: 0 - no calcification, 1 - mild calcification; 2 - moderate calcification, 3 -
significant calcification. Assessment of adherence of leaflets.
L-Hydro® group
1
2
3
4
5
6
7
8
9
10
11
12
16
17
Glutaraldehyde group
13
14
15
Calcification of leaflet
0
0
0
0
1
0
0
0
0
0
0
0
0
0
Calcification of leaflet
2
3
3
Calcification of tube
0
1
0
0
0
1
0
0
0
0
0
0
0
0
Calcification of tube
2
3
3
Adherence of leaflet (s)-(N)
3
0
0
2
0
0
1
1
3
0
3
2
0
0
Adherence of leaflet (s)-(N)
0
0
0
(N = Number of leaflets adhered)
Fig. 3 - Macroscopic post-explant. Total adherence of the leaflets
to the tube wall (Group L-Hydro ®)
Table 4. Statistical analysis of macroscopy (L-Hydro® and Glutaraldehyde groups).
Variable*
Calcification (moderate / significant) of
the cusps (macroscopy)
Calcification (moderate / significant) of
the tube (macroscopy)
Adherence of leaflets (microscopy)
L-Hydro®
group (n=14)
__
__
7 (50%)
Glutaraldehyde group
(n=3)
3 (100%)
3 (100%)
__
P Value†
0.001
0.001
0.228
were no signs of adherence to the tube wall leaflets in the
Glutaraldehyde Group.
Calcification in the variables of tubes and calcification
of leaflets significant (P = 0.001) in the comparison between
L-HydroR and Glutaraldehyde Groups. In the variable
adherence of leaflets, this statistical difference was not
observed (P = 0.228), as shown in Table 4.
Microscopic evaluation was performed in 16 animals,
13 in L-HydroR Group and three in  Glutaraldehyde Group
(Table 5). The staining by hematoxylin-eosin showed signs
of calcification in the cusps of seven of the 13 animals in L-
HydroR Group(53.8%), and the tube of ten of the 13 animals
of the same group (77%). This was calcification, but it was
classified as mild in all cases. No animal in L-HydroR Group
had moderate or severe calcification of cuspids or tube
(Figure 4).
Microscopic examination of the animals in
Glutaraldehyde Group showed significant calcification of
all cusps and fragments of pipe measured. The microscopy
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Table 5. Measurement of calcification: 0 - no calcification, 1 -
mild calcification, 2 - moderate calcification, 3 -
significant calcification.
L-Hydro® group
1
2
3
4
5
6
7
8
9
10
11
12
16
17
Glutaraldehyde
group
13
14
15
Calcification of
leaflet
NE
1
1
0
1
0
0
0
1
0
1
1
1
0
Calcification of
leaflets
3
3
3
Calcification of
tube
NE
1
1
0
1
1
1
0
1
1
1
1
1
0
Calcification of
tube
3
3
3
NE = Not evaluated
Fig. 4 - Microscopic view of the prosthesis preserved in L-Hydro
®. Staining with hematoxylin-eosin. In lilac, isolated spots of
calcification
Fig. 5 - Microscopic (optical microscopy) prosthesis preserved in
glutaraldehyde. Staining with hematoxylin-eosin. In lilac, diffuse
regions of calcification and severe
also showed macrophage inflammatory fibrinoid deposits
and absence of thrombi or clots in the samples analyzed in
both groups (Figure 5).
The statistical analysis shows significant difference (P
= 0.001) in the variables calcification of cusps and tube in
the comparison between L-HydroR and Glutaraldehyde
Groups (Table 6).
The dosage of calcium by atomic absorption
spectrophotometry showed a higher concentration of
calcium in the implants preserved in glutaraldehyde,
compared to those preserved in L-HydroR (P= 0.017). Table
7 shows the values obtained from this technique.
Table 6. Statistical analysis of microscopy (L-Hydro® and
Glutaraldehyde groups).
Variable*
Calcification
(moderate /
significant) of
the cusps
(microscopy)
Calcification
(moderate /
significant) of
the tube
(microscopy)
L-Hydro®
group
(n=14)
__
__
Glutaraldehyde
group
(n=3)
3 (100%)
3 (100%)
P
Value†
0.001
0.001
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Table 7. Dosing Calcium (mg/mg) by atomic absorption
spectrophotometry.
L-Hydro group®
1
2
3
4
5
6
7
8
9
10
11
12
16
17
Glutaraldehyde group
13
14
15
Atomic Absorption
43.84
139.44
48.7
14.2
25.7
240.9
206.6
98.3
58.39
53.76
38.97
22.4
64.04
50.01
Atomic Absorption
318.3
193.32
720.3
DISCUSSION
The implantation of biological valve prostheses that
allow and promote spontaneous coating with host cells
was proposed by Frater et al. [21] and is the principle behind
the development of L-HydroR preservation used in this
study. In the present study, we used as a preserving agent
L-HydroR tube valved bovine pericardium implanted in the
outflow of the right ventricle of sheep. These animals have
been used by several authors and have the characteristic
of being docile and allow easy handling during the test
period. In the case of large animal and fast growth and
development, pathophysiological changes resemble those
that occur in man during life. The time of at least 150 days
was necessary for the sheep present height and weight
development compatible with the proper adulthood [26]
can be verified or not the occurrence of calcification, as
well as analyze, this type of bioprosthesis, the hemodynamic
performance of the same, as far as wear.
Like the studies of Nina et al. in 2003 [22], Santos et al.
in 2007 [23] and Rey et al. in 2011 [24], the radiological
assessment, the present study demonstrate a significant
difference in the verification of calcification of the prosthesis
had preservation with L-HydroR, versus those that were
preserved in glutaraldehyde. The latter with a greater degree
of calcification. Likewise, the example of these studies,
macroscopic and microscopic evaluation showed a greater
degree of calcification in bioprostheses preserved in
glutaraldehyde. In relation to microscopy, the results show
higher calcification of glutaraldehyde preserved grafts, as
well as studies Nina et al. [22] and Santos et al. [23]. In the
case of prostheses preserved in L-HydroR, Nina et al. [22],
observed by scanning electron microscopy, the formation
of a new endothelium-resistant exudation of plasma proteins
and salts, which are precursors of bioprosthetic
degeneration. In their his remarks, Nina et al. [22] concluded
that the absence of toxicity, characteristic of L-HydroR
preservation, allowed the matrix of the prosthesis from the
test group became biocompatible, allowing for spontaneous
re-endothelialization, enhancing the resistance to
calcification and thrombogenicity.
By scanning electron microscopy and transmission
electron microscopy, Rey et al. [24] showed histological
evidence of interstitial and endothelial repopulation on the
surface of homografts preserved in L-HydroR implanted in
sheep. PEG is attributed to the immunosuppressive property,
which is based on L-HydroR preservation. As shown by
Collins et al. in 1991 [11], antigens that are combined with
PEG, have reduced antigenicity. Wicomb et al. in 1992 [15]
demonstrated the reduced toxicity of PEG when added to
the solution of this substance myocardial preservation,
ensuring viability of the organ for a longer time when
compared to conventional cardioplegic solutions.
It was observed the occurrence of adhesion of part or
all of the prosthetic leaflets in  L-HydroR Group (seven
animals), compared to Group Glutaraldehyde, where this
event has not been verified. One possible explanation for
this  is the fact that bioprostheses preserved in L-HydroR
have, since its preparation, a feature thinner and more flexible
compared to prostheses preserved in glutaraldehyde. As
the outflow of the right ventricle a low pressure zone, the
cusps more flexible would be susceptible to adhere to the
tube wall. Changing the design of the prosthesis with the
construction of breasts immediately above the valve could
perhaps reduce the incidence of adhesions.
Accordingly, further studies testing this new type of
prosthesis would allow evaluation of their performance.
Rey et al. [24] in their experimental study with homografts
preserved in L-HydroR found from the optical microscopy,
slightly retracted cusps with progressive thinning toward
the free edge. The atomic absorption spectroscopy, as well
as macro and microscopic evaluations, showed higher
concentrations of calcium in the prosthetic  Glutaraldehyde
Group. There were significant, which proves the feasibility
evaluation of calcium by this method [27].
This study presents a limitation to the inability to
reproduce the effect of heart disease and coagulation profile
comparable to that of man, like others who have used large
animals in the evaluation of new technologies for
preservation or replacement of cardiac tissues [5,17].
Moreover, animal models, although similar to the human
anatomy, have different antigenicity, which may lead to
non-reproducible results when the clinical use [12]. In the
present study, replacing the pulmonary valve with atubular
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